Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab After Marketing Approval in Spain

NCT07013760 · clinicaltrials.gov ↗
COMPLETED
Status
420
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AstraZeneca